Asha Jonathan Bowen Carapetis AM AC JR BA MBBS DCH FRACP PhD GAICD OAM AM MBBS FRACP FAFPHM PhD FAHMS Head, Healthy Skin and ARF Prevention Executive Director; Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@telethonkids.org.au ...

• 1. Telethon Kids Institute
• Our research
• Early Environment
• Developmental Origins of Child Health
• Expired projects

Asha Bowen AC BA MBBS DCH FRACP PhD GAICD OAM Head, Healthy Skin and ARF Prevention Head, Healthy Skin and Arf Prevention Areas of expertise: Skin infections, clinical trials, Streptococcus pyogenes, Staphylococcus aureus, Aboriginal children, COVID ...

• 1. Telethon Kids Institute
• Our research
• Past teams
• Skin Health

Asha Janessa Tim Bowen Pickering Barnett AC Dr TB BA MBBS DCH FRACP PhD GAICD OAM BSc PhD PhD Head, Healthy Skin and ARF Prevention Senior Research Fellow (currently HOT NORTH Early Career Fellow) Head of the Strep A Pathogenesis & Diagnostics team, ...

• 1. Telethon Kids Institute
• Projects

Scabies infestations are difficult to diagnose clinically and current serologic tests have less than 50% accuracy... ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2011
• September 2011

B-cell dysfunction persists in patients with HIV receiving long-term antiretroviral therapy. the causes and consequences of this require further investigation. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2016
• April 2016

Children in Papua New Guinea (PNG) are at high risk of pneumococcal infections. We investigated pneumococcal carriage rates, serotype distribution, and antimicrobial susceptibility in PNG children after vaccination with 10-valent or 13-valent pneumococcal conjugate vaccines (PCV10; PCV13). ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• July 2023

The authors present a variety of pressing clinical research questions on optimal RHD prevention and advanced care ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2018
• September 2018

A range of safe and effective vaccines against SARS CoV 2 are needed to address the COVID 19 pandemic. We aimed to assess the safety and efficacy of the COVID-19 vaccine SCB-2019. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• January 2022

The purpose of this double-blind, randomised, controlled trial is to compare allergic outcomes in children following vaccination with acellular pertussis (aP) antigen (standard of care in Australia) given at 2 months of age versus whole cell pertussis (wP) in the infant vaccine schedule. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• February 2022

Whether vaccination during pregnancy could reduce the burden of respiratory syncytial virus (RSV)-associated lower respiratory tract illness in newborns and infants is uncertain. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• April 2023

To assess the immunogenicity and safety of a 2009 influenza A(H1N1) vaccine in children. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2010
• January 2010

This study evaluated GSK's combined DTPa-IPV vaccine (Infanrix-IPV) given as a fifth consecutive acellular pertussis booster dose in conjunction... ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2006
• August 2006